Description |
phosphodiesterase 4B |
protein kinase cAMP-activated catalytic subunit alpha |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Pentanal
- Balanol Analog 2
- 3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate
- Phosphonothreonine
- Balanol Analog 1
- 3,5-Diiodotyrosine
- Balanol
- Dexfosfoserine
- S,S-(2-Hydroxyethyl)Thiocysteine
- Hydroxyfasudil
- (2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine
- (2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine
- (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE
- (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
- (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
- N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE
- 3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione
- (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
- N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
- (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE
- 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE
- (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
- (2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
- 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
- (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE
- (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE
- ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
- H-89
- 5-(2-methylpiperazine-1-sulfonyl)isoquinoline
- N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
- 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
- (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
- 3-pyridin-4-yl-1H-indazole
- 5-benzyl-1,3-thiazol-2-amine
- 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
- 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine
- 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium
- Fasudil
- Myristic acid
- A-674563
- 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE
- Y-27632
- Ellagic acid
- Fostamatinib
|
Diseases |
|
|
GWAS |
- Acute lymphoblastic leukemia (childhood) ( 22076464 23007406)
- Adult body size ( 32376654)
- Age at voice drop ( 27182965)
- Alcohol consumption ( 31358974)
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Anxiety and stress-related disorders ( 31116379)
- Anxiety and stress-related disorders (excluding adjustment disorder) ( 31116379)
- Anxiety and stress-related disorders (excluding co-morbid schizophrenia) ( 31116379)
- Anxiety and stress-related disorders (including obsessive-compulsive disorder) ( 31116379)
- Anxiety and stress-related disorders (psychiatric co-morbidity covariate model) ( 31116379)
- Anxiety and stress-related disorders (psychiatric co-morbidity weighting design) ( 31116379)
- Anxiety disorders ( 31116379)
- Birth weight ( 31043758)
- Body size at age 10 ( 32376654)
- Chronotype ( 30696823)
- Echocardiographic traits ( 17903301)
- Economic and political preferences (feminism/equality) ( 22566634)
- Fibrinogen levels ( 28107422)
- Gastroesophageal reflux disease ( 31527586)
- Low tan response ( 29739929)
- Multiple sclerosis ( 31604244)
- Phenylephrine infusion rate during anesthesia ( 31455332)
- Problematic alcohol use ( 32451486)
- QT interval ( 29213071)
- Risk-taking tendency (4-domain principal component model) ( 30643258)
- Rosacea symptom severity ( 29771307)
- Schizophrenia ( 30285260)
- Sleep duration (short sleep) ( 30846698)
- Smoking initiation ( 30617275)
- Smoking initiation (ever regular vs never regular) ( 30679032)
- Smoking status (ever vs never smokers) ( 30643258)
- Staphylococcus aureus infection ( 24847357)
- Stress-related disorders ( 31116379)
|
|
Interacting Genes |
5 interacting genes:
DISC1
MAGEA11
PRKACA
RCBTB2
SMURF2
|
205 interacting genes:
AANAT
ABCA1
ACLY
ADCY5
ADD1
ADD2
AKAP14
AKAP8L
AKIP1
ANXA7
APC
APOBEC3G
ARFGEF3
ASIC1
ASIC3
ATF1
ATP2B1
AURKA
AVPI1
BAD
BCL2
BRAF
CACNA1C
CACNB2
CACNG2
CAD
CALD1
CAMKK2
CCDC88A
CCND1
CDK16
CDKN1A
CETN1
CFTR
CIITA
CLDN3
CLTC
CREB1
CREM
CRK
CSK
CUL5
CYP3A4
DMTN
DNAJC5
DOCK1
DRD1
DSP
EEF2K
EGFR
ERBB3
ESR1
ETV1
FBXW11
FOS
FXYD1
GABRB3
GABRR1
GAD1
GAD2
GFAP
GJA5
GJB1
GLI1
GMFB
GNA13
GNMT
GP1BB
GRIA1
GRIA4
GRK2
GSK3A
GSK3B
GUSB
GYS1
HAND1
HAND2
HDAC1
HDAC8
HIF1A
HMGCR
HMGN1
HMGN2
HNF4A
HNRNPD
HSP90AA1
HSPA4
HSPD1
IFNAR1
IQGAP1
IRF2
ITCH
ITGA2B
ITGA4
ITPKA
ITPKB
ITPR1
ITPR2
KCNH2
KCNJ12
KCNQ1
KDELR1
KLF1
KLHL3
LCK
LCP1
LIPE
LRP1
MAP2
MAP3K3
MAPT
MBP
MC4R
MEF2D
MEP1B
MGMT
MIP
NDRG1
NFKB1
NIN
NOLC1
NOS1
NOXA1
NR3C1
NSFL1C
NUP85
PDC
PDE3A
PDE3B
PDE4B
PDE4D
PDPK1
PFKFB1
PFKFB2
PHKA1
PHOX2A
PKIA
PKIB
PLIN1
PLN
POU2F1
PPP1R10
PPP1R17
PPP1R1B
PPP1R8
PPP1R9B
PRKAR1A
PRKAR1B
PRKAR2B
PSEN1
PSMD11
PTBP1
PTPN12
PTPN13
PTPN7
PTPRR
RAF1
RANBP9
RAP1A
RAP1B
RAP1GAP
RASGRF1
RASGRP3
RELA
RGS10
RGS13
RGS14
RHOA
RRAD
RSBN1
RYR1
RYR2
SI
SIK1
SIK3
SLC2A2
SLC4A4
SLC9A3R2
SNAP25
SNAPIN
SNPH
SPTBN1
SRC
STK11
STMN1
STMN2
STUB1
SYN1
SYN2
TH
THOP1
TNP1
TNP2
TPH1
TRIM55
TRIM63
TRIP10
UBE3A
UHRF1
USP20
VASP
VIM
VTN
WT1
YWHAZ
|
Entrez ID |
5142 |
5566 |
HPRD ID |
02528 |
03382 |
Ensembl ID |
ENSG00000184588
|
ENSG00000072062
|
Uniprot IDs |
Q07343
Q59GM8
Q68CX5
X5DNX5
X5DR82
|
A0A024R7J0
A8K8B9
P17612
|
PDB IDs |
1F0J
1JP1
1JP2
1RO6
1RO9
1ROR
1TB5
1XLX
1XLZ
1XM4
1XM6
1XMU
1XMY
1XN0
1XOS
1XOT
1Y2H
1Y2J
2CHM
2QYL
3D3P
3FRG
3G45
3GWT
3HC8
3HDZ
3HMV
3KKT
3LY2
3O0J
3O56
3O57
3W5E
3WD9
4KP6
4MYQ
4NW7
4WZI
4X0F
5K6J
5LAQ
5OHJ
6BOJ
|
2GU8
3AGL
3AGM
3AMA
3AMB
3L9L
3L9M
3L9N
3MVJ
3NX8
3OOG
3OVV
3OWP
3OXT
3P0M
3POO
3VQH
4AE6
4AE9
4UJ1
4UJ2
4UJ9
4UJA
4UJB
4WB5
4WB6
4WB7
4WB8
5BX6
5BX7
5IZF
5IZJ
5J5X
5N23
5UZK
6BYR
6BYS
6C0U
6FRX
6NO7
6QJ7
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|